TY - JOUR
T1 - The Glucagonoma Syndrome (Necrolytic Migratory Erythema) and Zinc
AU - Amon, Robert B.
AU - Swenson, Keith H.
AU - Hanifin, Jon M.
AU - Hambidge, K. Michael
PY - 1976/10/21
Y1 - 1976/10/21
N2 - To the Editor: We agree with Drs. Tasman-Jones and Kay (N Engl J Med 293:830, 1975) that the skin lesions that occur in patients with the glucagonoma syndrome closely mirror those present in patients with acute zinc deficiency. Recently, however, we had the opportunity to diagnose and manage a 19-year-old woman with the glucagonoma syndrome whose serum zinc level was 93 μg per 100 ml (normal, 68 to 110). The diagnosis was established on the basis of clinical signs (necrolytic migratory erythema and glossitis), a fivefold elevation of plasma glucagon levels and electron microscopy of surgical tissue demonstrating the. . . No extract is available for articles shorter than 400 words.
AB - To the Editor: We agree with Drs. Tasman-Jones and Kay (N Engl J Med 293:830, 1975) that the skin lesions that occur in patients with the glucagonoma syndrome closely mirror those present in patients with acute zinc deficiency. Recently, however, we had the opportunity to diagnose and manage a 19-year-old woman with the glucagonoma syndrome whose serum zinc level was 93 μg per 100 ml (normal, 68 to 110). The diagnosis was established on the basis of clinical signs (necrolytic migratory erythema and glossitis), a fivefold elevation of plasma glucagon levels and electron microscopy of surgical tissue demonstrating the. . . No extract is available for articles shorter than 400 words.
UR - http://www.scopus.com/inward/record.url?scp=0017313018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017313018&partnerID=8YFLogxK
U2 - 10.1056/NEJM197610212951717
DO - 10.1056/NEJM197610212951717
M3 - Letter
C2 - 184387
AN - SCOPUS:0017313018
SN - 0028-4793
VL - 295
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 17
ER -